Related Experiment Video
Updated: Mar 12, 2026
10:49
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
9.5K
Options for improving effectiveness of rotavirus vaccines in developing countries
Marion S Tissera1, Daniel Cowley2, Nada Bogdanovic-Sakran2
1a Department of Paediatrics , Monash University, Melbourne, Australia; Enteric Virus Group, Murdoch Childrens Research Institute , Melbourne , Australia.
Human Vaccines & Immunotherapeutics
|November 12, 2016
Summary
Rotavirus vaccines are highly effective in developed nations but less so in developing countries. Research is exploring strategies to close this efficacy gap and save more young lives globally.
Area of Science:
- Pediatrics
- Vaccinology
- Infectious Diseases
Background:
- Rotavirus gastroenteritis is a major cause of childhood mortality and morbidity, particularly in developing nations.
- Live oral rotavirus vaccines show high effectiveness (>90%) in industrialized countries.
- The same vaccines demonstrate reduced efficacy (30-60%) in developing countries, despite being life-saving.
Purpose of the Study:
- To review strategies aimed at bridging the rotavirus vaccine efficacy gap in developing countries.
- To address the reduced effectiveness of oral rotavirus vaccines in low-resource settings.
Main Methods:
- This is a review article examining current research strategies.
- Focuses on factors influencing vaccine performance in diverse settings.
Main Results:
- Rotavirus vaccines are life-saving globally, but efficacy varies significantly between regions.
- The "efficacy gap" highlights a critical area for public health intervention.
Conclusions:
- Understanding and addressing factors like transmission dynamics and host-related elements is crucial.
- Developing improved rotavirus vaccine strategies is essential to reduce childhood mortality worldwide.
